Nephrocalcinosis or nephrolithiasis

Gene: ATP6V1B1

Green List (high evidence)

ATP6V1B1 (ATPase H+ transporting V1 subunit B1)
EnsemblGeneIds (GRCh38): ENSG00000116039
EnsemblGeneIds (GRCh37): ENSG00000116039
OMIM: 192132, Gene2Phenotype
ATP6V1B1 is in 6 panels

4 reviews

Ida Ertmanska (Genomics England Curator)

The mode of inheritance of this gene has been updated to BOTH monoallelic and biallelic, autosomal or pseudoautosomal following NHS Genomic Medicine Service approval.
Created: 10 Dec 2025, 3:14 p.m. | Last Modified: 10 Dec 2025, 3:14 p.m.
Panel Version: 5.4

Sarah Leigh (Genomics England Curator)

Green List (high evidence)

Using a retrospective analysis of twenty index patients with distal renal tubular acidosis (OMIM:267300), Daenen et al (PMID: 39837581) report heterozygous ATP6V1B1(NM_001692.4):c.1181G>A, p.(Arg394Gln) in 19 cases and one case who was heterozygous for ATP6V1B1(NM_001692.4): c.1180C>G; p.(Arg394Gly) from seven families, in contrast to the previously reported biallelic ATP6V1B1 associated with OMIM:267300 (PMID: 9916796; 12566520; 18798332). The variants segregate with the condition in six of the families, in the remaining family (family D) the unaffected mother is mosaic for the ATP6V1B1(NM_001692.4):c.1181G>A, p.(Arg394Gln) and her two sons are heterozygous for the variant (figure 1, PMID: 39837581).

The acidosis associated with the heterozygous ATP6V1B1 p. Arg394 variants appears to be similar to that in the homozygous cases previously reported (PMID: 9916796; 12566520; 18798332). However, the sensorineural hearing loss was milder or absent from the heterozygous cohort (PMID: 39837581).

Using structural modelling, Daenen et al suggest that a dominant negative disease mechanism could be responsible for the effect of the heterozygous ATP6V1B1 p. Arg394 variants (PMID: 39837581).
Created: 7 Apr 2025, 3:35 p.m. | Last Modified: 7 Apr 2025, 3:35 p.m.
Panel Version: 4.20

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Distal renal tubular acidosis 2 with progressive sensorineural hearing loss, OMIM:267300; renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss, MONDO:0009968

Publications

Celia Duff-Farrier (North Bristol NHS Trust)

Green List (high evidence)

Strong evidence for the pathogenicity of heterozygous variants affecting ATP6V1B1 Arg394 and thus a novel inheritance modus for ATP6V1B1-associated dRTA. The mode of inheritance can therefore be considered BOTH monoallelic and biallelic. The prominent position of Arg394 in the nucleotide binding fold of the H+-ATPase structure is consistent with a dominant negative mechanism. (PMID 39837581)
Created: 17 Feb 2025, 5:32 p.m. | Last Modified: 17 Feb 2025, 5:32 p.m.
Panel Version: 4.19

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Publications

Variants in this GENE are reported as part of current diagnostic practice

Ellen Thomas (Genomics England Curator)

Comment on list classification: Can include renal stones, primarily a renal tubular acidosis gene.
Created: 23 May 2016, 12:30 p.m.

Details

Mode of Inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • NHS GMS
  • Expert Review Green
  • Eligibility statement prior genetic testing
  • Expert
Phenotypes
  • Distal renal tubular acidosis 2 with progressive sensorineural hearing loss, OMIM:267300
  • renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss, MONDO:0009968
OMIM
192132
Clinvar variants
Variants in ATP6V1B1
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

10 Dec 2025, Gel status: 3

Removed Tag, Removed Tag

Ida Ertmanska (Genomics England Curator)

Tag Q2_25_ MOI was removed from gene: ATP6V1B1. Tag Q2_25_ NHS_review was removed from gene: ATP6V1B1.

10 Dec 2025, Gel status: 3

Added New Source, Set mode of inheritance

Ida Ertmanska (Genomics England Curator)

Source NHS GMS was added to ATP6V1B1. Mode of inheritance for gene ATP6V1B1 was changed from BIALLELIC, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

7 Apr 2025, Gel status: 3

Added Tag, Added Tag

Sarah Leigh (Genomics England Curator)

Tag Q2_25_ MOI tag was added to gene: ATP6V1B1. Tag Q2_25_ NHS_review tag was added to gene: ATP6V1B1.

7 Apr 2025, Gel status: 3

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: ATP6V1B1 were changed from distal renal tubular acidosis; Renal tubular acidosis with deafness 267300 to Distal renal tubular acidosis 2 with progressive sensorineural hearing loss, OMIM:267300; renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss, MONDO:0009968

7 Apr 2025, Gel status: 3

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: ATP6V1B1 were set to 39837581

7 Apr 2025, Gel status: 3

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: ATP6V1B1 were set to

6 Nov 2019, Gel status: 3

Set Phenotypes

Eleanor Williams (Genomics England Curator)

Phenotypes for gene: ATP6V1B1 were changed from distal renal tubular acidosis to distal renal tubular acidosis; Renal tubular acidosis with deafness 267300

23 May 2016, Gel status: 4

Gene classified by Genomics England curator

Ellen Thomas (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

23 May 2016, Gel status: 4

Gene classified by Genomics England curator

Ellen Thomas (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

20 May 2016, Gel status: 2

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Amber List (Moderate Evidence).

12 Aug 2015, Gel status: 0

Added New Source

Ellen McDonagh (Genomics England Curator)

ATP6V1B1 was added to Renal tract calcification (or Nephrolithiasis/nephrocalcinosis)panel. Sources: Eligibility statement prior genetic testing

8 May 2015, Gel status: 0

Added New Source

Eik Haraldsdottir (Genomics England)

ATP6V1B1 was added to Renal tract calcification (or Nephrolithiasis/nephrocalcinosis)panel. Sources: Expert